A public US share offering of Pieris Pharmaceuticals Inc (formerly Pieris AG) has raised a gross amount of $25 million following the sale of 9,090,909 new shares to international investors. The net proceeds are expected to be $22.7 million. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
